Key result
Nuclear magnetic resonance (NMR) imaging is an appropriate technology for the application of cost-benefit and cost-effectiveness analyses.
Highlights the utility of cost-benefit and cost-effectiveness analyses for evaluating the implementation of new medical technologies such as nuclear magnetic resonance imaging.
May inform economic evaluation of NMR imaging; leaves open effects on clinical adoption or guidelines.
Any new technology that promises significant costs as well as potential benefits generates considerable interest. Such innovations bring into bold relief the fundamental problem of achieving maximal medical benefits while efficiently and equitably allocating scarce resources (II). Two tools that decision makers can use to assess the benefits and costs of implementing new technologies are cost- benefit analysis (CBA) and cost-effectiveness analysis (CEA). One technology that seems especially appropriate for the application of CBA and CEA is nuclear magnetic resonance (NMR) imaging.
No takes yet. Share an insight, caveat, or question.
Gillespie et al. (1985) reported a review. Nuclear magnetic resonance (NMR) imaging was evaluated. Nuclear magnetic resonance (NMR) imaging is an appropriate technology for the application of cost-benefit and cost-effectiveness analyses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: